Turning Dysfunction After Stroke: Assessment and Intervention
13 de diciembre de 2020 actualizado por: Pei Jung Liang, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Turning Dysfunction After Stroke And Its Association To Trunk Control: Underlying Mechanisms And Training Effects
The study aims to investigate the 1) differences between stroke patients and healthy controls in time, steps, angular velocity, stepping patterns, electromyographic responses during turning, and the association of turning to trunk control and motor function after stroke; 2) the effectiveness of trunk training on turning performance, trunk control and motor function in stroke patients.
Descripción general del estudio
Estado
Terminado
Condiciones
Intervención / Tratamiento
Descripción detallada
This study has two parts.
The first part is a cross-sectional observatory study.Eligible stroke and healthy subjects are asked their demographic data and assessed for turning performance (stepping patterns and electromyography data of trunk muscles), trunk control (muscle strength, active range of motion, muscle mass and motor control in trunk) and motor function (recovery of extremities and balance function).
The second part is a randomized controlled trial.
Stroke participants are randomly allocated into trunk exercise and control groups.
Trunk exercise group receives trunk exercise including trunk muscles stretching, trunk muscles strengthening, and task-related trunk control training for 30 minutes per session, twice a week for 12 weeks while control group remains their regular activities.
Turning performance, trunk control and motor function are evaluated before and after training session.
Tipo de estudio
Intervencionista
Inscripción (Actual)
42
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
-
New Taipei City, Taiwán
- Taipei Tzu Chi Hospital
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
20 años a 80 años (Adulto, Adulto Mayor)
Acepta Voluntarios Saludables
Sí
Géneros elegibles para el estudio
Todos
Descripción
Inclusion Criteria:
- age between 20 and 80 years old
- survivors of a single and unilateral stroke with hemiparesis experienced at least 6 months prior to their participation in the study
- able to walk independently over a distance of 10 m without walking aids or orthoses
- able to provide informed consent and follow instructions.
Exclusion Criteria:
- having additional musculoskeletal conditions or comorbid disabilities that could affect the assessment
- having cognitive problems with a Mini-Mental State Examination score less than 24 or aphasia that could prevent subjects from following instructions.
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Trunk exercise group
Participants received trunk exercise for 30 minutes per session, twice a week for 12 weeks.
|
Trunk exercise includes trunk muscles stretching, trunk muscles strengthening, and task-related trunk control training for 30 minutes per session, twice a week for 12 weeks.
|
|
Sin intervención: Control group
Participants remained their regular activities.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change from Baseline in turning duration at Week 12
Periodo de tiempo: Baseline and Week 12
|
Turning duration (s) was recorded during turning 360-degree in place using APDM Opal wireless sensors.
Longer duration represents poorer turning performance.
|
Baseline and Week 12
|
|
Change from Baseline in turning angular velocity at Week 12
Periodo de tiempo: Baseline and Week 12
|
Angular velocity (m/s2) was recorded during turning 360-degree in place using APDM Opal wireless sensors.
Slower angular velocity represents instability during turning.
|
Baseline and Week 12
|
|
Change from Baseline in trunk muscles electromyography during turning at Week 12
Periodo de tiempo: Baseline and Week 12
|
Muscle activation patterns (amplitude, % reference voluntary contraction) are observed in bilateral External abdominal oblique (EO) and erector spinae (ES) through an electromyographic analysis.
Greater muscle amplitude represents greater muscle contraction.
|
Baseline and Week 12
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change from Baseline in trunk range of motion at Week 12
Periodo de tiempo: Baseline and Week 12
|
The trunk range of motion (ROM) was measured using a tape measure in sitting position.
The spinous processes at C7 and S1 served as landmarks for placement of the tape and measurement for trunk flexion and extension ROM.
The length between iliac crest and contralateral acromion of scapula was measured for trunk rotation ROM while the distance between the tip of the middle finger and the floor for trunk lateral flexion ROM.
The difference between tape measures in starting and ending positions was calculated for all trunk movement directions.
Greater value of trunk flexion and rotation but smaller value of trunk extension and lateral flexion represents better trunk ROM.
|
Baseline and Week 12
|
|
Change from Baseline in trunk muscles strength at Week 12
Periodo de tiempo: Baseline and Week 12
|
Trunk flexors, extensors, rotators, and lateral flexors strength were measured using a MicroFET3 dynamometer.
Participants were asked to generate the maximum trunk flexion, extension, rotation bilaterally and lateral flexion bilaterally for a period of 6 seconds each.
Resistance was applied using the dynamometer to obtain the value of each trunk muscle (kg).
Greater value represents greater muscle strength.
|
Baseline and Week 12
|
|
Change from Baseline in Trunk Impairment Scale at Week 12
Periodo de tiempo: Baseline and Week 12
|
Trunk control was assessed by the Trunk Impairment Scale (TIS) which has good inter-rater reliability with intra-class coefficient 0.85-0.99 and internal consistency with Cronbach's α 0.65-0.89.
The TIS evaluates static and dynamic sitting balance and trunk coordination in a sitting position.
On the static and dynamic sitting balance and coordination subscales the maximal scores that can be attained are 7, 10 and 6 points.
The total score for TIS ranges between 0 for a minimal performance to 23 for a perfect performance.
|
Baseline and Week 12
|
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change from Baseline in Modified Clinical Test of Sensory Integration and Balance at Week 12
Periodo de tiempo: Baseline and Week 12
|
Modified Clinical Test of Sensory Integration and Balance (mCTSIB) is designed to assess how well an older adult is using sensory inputs when one or more sensory systems are compromised.
The postural sway was measured in 4 sensory conditions through visual and proprioceptive manipulation using APDM Opal wireless sensors.
The greater postural sway represents the poorer balance.
|
Baseline and Week 12
|
|
Change from Baseline in Berg Balance Scale at Week 12
Periodo de tiempo: Baseline and Week 12
|
The Berg balance scale (BBS) is used to objectively determine a participant's ability to safely balance during a series of predetermined tasks.
It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function.
The total score is 56.
|
Baseline and Week 12
|
|
Change from Baseline in Timed Up and Go test at Week 12
Periodo de tiempo: Baseline and Week 12
|
Function mobility was assessed by the Timed Up and Go (TUG) test.
Participants were instructed to stand up from a chair, walk 3 meters, turn around, and walk back to the chair sit down.
Time to complete the task was recorded.
The more time taken is representative of the lower level of functional mobility.
|
Baseline and Week 12
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Colaboradores
Investigadores
- Investigador principal: Pei-Jung Liang, Taichung Tzu Chi Hospital
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
13 de julio de 2020
Finalización primaria (Actual)
31 de octubre de 2020
Finalización del estudio (Actual)
31 de octubre de 2020
Fechas de registro del estudio
Enviado por primera vez
8 de diciembre de 2020
Primero enviado que cumplió con los criterios de control de calidad
13 de diciembre de 2020
Publicado por primera vez (Actual)
16 de diciembre de 2020
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
16 de diciembre de 2020
Última actualización enviada que cumplió con los criterios de control de calidad
13 de diciembre de 2020
Última verificación
1 de diciembre de 2020
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 08-XD-051
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .